Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-059277
Date:2019-12-03
Issuer: CRISPR THERAPEUTICS AG (CRSP)
Original Submission Date:

Reporting Person:

HO TONY W
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2019-12-03 deemed execution date A 40,000 (a) common shares 40,000 $0.00 40,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of crsp common shares.
f2 the restricted stock units shall vest as follows: two-thirds of the grant shall vest on december 3, 2021 and the remaining one-third shall vest on december 3, 2022
WhaleWisdom Logo

Elevate your investments